RecruitingPhase 1NCT06937528

Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis

Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Extracellular Vesicles (EV) for Advanced Stage III and IV KOA

Sponsor

University of Jordan

Enrollment

50 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Knee Osteoarthrosis

Summary

Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis

Eligibility

Min Age: 42 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Extracellular vesicles for people with knee osteoarthrosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 42 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALExtracellular vesicles

Intra-articular extravascular vesicles injection.

Locations(1)

Cell Therapy Center

Amman, Jordan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06937528